A review of blood-brain barrier transport techniques.

[1]  T. Reese,et al.  JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN , 1969, The Journal of cell biology.

[2]  R. Bendayan,et al.  Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. , 2001, Pharmacological reviews.

[3]  E. M. Renkin.  Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. , 1959, The American journal of physiology.

[4]  S. Rapoport,et al.  Cerebrovascular Permeability Coefficients to Sodium, Potassium, and Chloride , 1986, Journal of neurochemistry.

[5]  W. Elmquist,et al.  Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain. , 2001, The Journal of pharmacology and experimental therapeutics.

[6]  S. Rapoport,et al.  2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-brain barrier permeability in the rat. , 1991, The Journal of pharmacology and experimental therapeutics.

[7]  Ronald G. Blasberg,et al.  Transport of α-Aminoisobutyric Acid across Brain Capillary and Cellular Membranes , 1983 .

[8]  S. Vannucci,et al.  Glucose Transporter Asymmetries in the Bovine Blood-Brain Barrier* , 2001, The Journal of Biological Chemistry.

[9]  S. Rapoport,et al.  Phenylalanine Transport Across the Blood‐Brain Barrier as Studied with the In Situ Brain Perfusion Technique , 1987, Journal of neurochemistry.

[10]  Q. Smith,et al.  Quantitation of Blood-Brain Barrier Permeability , 1989 .

[11]  Q. Smith,et al.  Characterization of the blood–brain barrier choline transporter using the in situ rat brain perfusion technique , 2001, Journal of neurochemistry.

[12]  H. Takanaga,et al.  ATA2 is predominantly expressed as system A at the blood-brain barrier and acts as brain-to-blood efflux transport for L-proline. , 2002, Molecular pharmacology.

[13]  W. Pardridge.  BBB-Genomics: creating new openings for brain-drug targeting. , 2001, Drug discovery today.

[14]  D. Begley,et al.  Measurement of Solute Transport Across the Blood–Brain Barrier in the Perfused Guinea Pig Brain: Method and Application to N‐Methyl‐α‐Aminoisobutyric Acid , 1986, Journal of neurochemistry.

[15]  R. Hawkins,et al.  Neutral Amino Acid Transport Characterization of Isolated Luminal and Abluminal Membranes of the Blood-Brain Barrier (*) , 1995, The Journal of Biological Chemistry.

[16]  T. Tsuruo,et al.  Efflux of a suppressive neurotransmitter, GABA, across the blood–brain barrier , 2001, Journal of neurochemistry.

[17]  N. Sposito,et al.  Differences in function and structure of the capillary endothelium in gray matter, white matter and a circumventricular organ of rat brain. , 1986, Blood vessels.

[18]  R. Egleton,et al.  Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier , 2001, Trends in Neurosciences.

[19]  S. Rapoport,et al.  An in situ brain perfusion technique to study cerebrovascular transport in the rat. , 1984, The American journal of physiology.

[20]  C. Rousselle,et al.  Screening of Multidrug-Resistance Sensitive Drugs by In Situ Brain Perfusion in P-Glycoprotein-Deficient Mice , 2001, Pharmaceutical Research.

[21]  M. Segal.  Introduction to the Blood–Brain Barrier: The blood-CSF barrier and the choroid plexus , 1998 .

[22]  S. Rapoport,et al.  Kinetics and distribution volumes for tracers of different sizes in the brain plasma space , 1988, Brain Research.

[23]  K D Pettigrew,et al.  Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. , 1978, The American journal of physiology.

[24]  J. Viña,et al.  Na+-dependent Glutamate Transporters (EAAT1, EAAT2, and EAAT3) of the Blood-Brain Barrier , 1999, The Journal of Biological Chemistry.

[25]  P. Kennedy.  Introduction to the Blood-Brain Barrier , 1994 .

[26]  O. Major,et al.  Continuous monitoring of blood-brain barrier opening to Cr51-EDTA by microdialysis following probe injury. , 1990, Acta neurochirurgica. Supplementum.

[27]  Q. Smith.  Transport of glutamate and other amino acids at the blood-brain barrier. , 2000, The Journal of nutrition.

[28]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[29]  R. Hawkins,et al.  Biochemical Discrimination between Luminal and Abluminal Enzyme and Transport Activities of the Blood-Brain Barrier (*) , 1995, The Journal of Biological Chemistry.

[30]  B. D. Anderson,et al.  Quantitative assessment of blood-brain barrier damage during microdialysis. , 1996, The Journal of pharmacology and experimental therapeutics.

[31]  R. Hawkins,et al.  Glucose transport by isolated plasma membranes of the bovine blood-brain barrier. , 1997, The American journal of physiology.

[32]  Y. Sawada,et al.  Comparison of blood-brain barrier permeability in mice and rats using in situ brain perfusion technique. , 2000, American journal of physiology. Heart and circulatory physiology.

[33]  W. Pardridge,et al.  Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma Proteins , 1990, Journal of neurochemistry.

[34]  Thomas S. Reese,et al.  FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE , 1967, The Journal of cell biology.

[35]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  K. Pettigrew,et al.  Drug entry into the brain , 1979, Brain Research.

[37]  M. Bradbury.  The concept of a blood-brain barrier , 1979 .

[38]  A. Hamberger,et al.  Intracerebral Dialysis and the Blood‐Brain Barrier , 1995, Journal of neurochemistry.

[39]  E. Neuwelt,et al.  Implications of the Blood-Brain Barrier and Its Manipulation , 1989, Springer US.

[40]  Meindert Danhof,et al.  Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood–brain barrier , 1997, Brain Research Reviews.

[41]  R. Keep,et al.  Introduction to the Blood–Brain Barrier: Blood–brain barrier ion transport , 1998 .

[42]  A. Butt,et al.  Effect of histamine and antagonists on electrical resistance across the blood-brain barrier in rat brain-surface microvessels , 1992, Brain Research.

[43]  Yanfeng Wang,et al.  Microdialysis Calibration Using Retrodialysis and Zero-Net Flux: Application to a Study of the Distribution of Zidovudine to Rabbit Cerebrospinal Fluid and Thalamus , 1993, Pharmaceutical Research.

[44]  Y. Sugiyama,et al.  Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier. , 1996, The Journal of pharmacology and experimental therapeutics.

[45]  Y. Sugiyama,et al.  Selective brain to blood efflux transport of para-aminohippuric acid across the blood-brain barrier: in vivo evidence by use of the brain efflux index method. , 1997, The Journal of pharmacology and experimental therapeutics.

[46]  K. Voigt,et al.  Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat. , 1996, The Journal of pharmacology and experimental therapeutics.

[47]  Q. Smith.  Brain perfusion systems for studies of drug uptake and metabolism in the central nervous system. , 1996, Pharmaceutical biotechnology.